ONCOPOLE_en

13 Dec 2021 | Unclassified

ONCOPOLE – Functional analysis of the inherited N363K POLE mutation in highly aggressive colon cancers and glioblastomas In rare cases, the occurrence of cancer is linked to an inherited genetic mutation, in which case there is a familial predisposition. Several...

MITHAML_en

13 Dec 2021 | Unclassified

MITHAML – Metabolic heterogeneity in acute myeloid leukaemia Accumulating evidence indicates that metabolism is involved in the drug resistance that develops in acute myeloid leukaemia (AML). However, approaches have so far assessed metabolism as a whole,...

PROTEOblood_en

10 Dec 2021 | Unclassified

PROTEOblood : Development of new therapies against two subtypes of lymphoma and leukaemia. Significant progress has recently been made in the diagnosis and selective treatment of certain blood cancers. However, most of these malignancies remain incurable. There is...

MEDIRAD_en

6 Dec 2021 | Unclassified

MEDIRAD – Consequences of medical exposure to low dose radiation The evolution of medical science and the increasing pace of innovation and deployment of medical technology have led to a situation where the majority of artificial ionising radiation exposure to...

PINICAL-MRT_en

6 Dec 2021 | Unclassified

PINICAL-MRT : Clinical impact protocols in molecular radiotherapy Development of guidelines to translate knowledge on molecular radiotherapy into clinical practice Article 56 of the EC Directive 2013/59/EURATOM, detailing the requirements for individual dose planning...

CIEL_en

6 Dec 2021 | Unclassified

CIEL The CIEL project (Immune escape and innate immunity in lymphoma), builds on the important research work previously carried out by the team on the mechanisms of immune escape (IE) in malignant lymphomas, and in particular on the development of a multiparametric...

Pin It on Pinterest